The global gene synthesis tool market is expected to grow at a CAGR of around 8.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing demand for gene synthesis tools in various industries such as food and agriculture, environmentals, industrials, and medicals. The increasing demand for these tools is due to their ability to produce large quantities of DNA sequences with high accuracy and precision. The global gene synthesis tool market by type is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms (plasmids), Xennucleic acids (XNO). The application segment includes food and agriculture industry; environmentals industry; industrials industry; medicals industry. North America region has the largest share in the global gene synthesis tool market followed by Europe region owing to its advanced healthcare infrastructure and availability of skilled workforce in this region. Asia Pacific region is expected to witness fastest growth during the forecast period owing to its growing pharmaceutical sector which will drive up demand for these tools in this region.
- The increasing demand for gene synthesis tools in the pharmaceutical industry is one of the major factors driving growth in this market.
- The increasing number of research and development activities in the field of gene synthesis tools is also driving growth in this market.
- Increasing investments by governments and private organizations are also contributing to growth in this market.
- Increasing awareness about gene synthesis tools among researchers, scientists, and other stakeholders is also contributing to growth in this market.
Industry Growth Insights published a new data on “Gene Synthesis Tool Market”. The research report is titled “Gene Synthesis Tool Market research by Types (Oligonucleotides, Enzymes, Cloning Technology Kits, Chassis Organisms, Xeno-nucleic Acids (XNO)), By Applications (Food and Agriculture, Environmentals, Industrials, Medicals, Others), By Players/Companies Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), Agilent Technologies (US)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Gene Synthesis Tool Market Research Report
By Type
Oligonucleotides, Enzymes, Cloning Technology Kits, Chassis Organisms, Xeno-nucleic Acids (XNO)
By Application
Food and Agriculture, Environmentals, Industrials, Medicals, Others
By Companies
Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), Agilent Technologies (US)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Gene Synthesis Tool Market Report Segments:
The global Gene Synthesis Tool market is segmented on the basis of:
Types
Oligonucleotides, Enzymes, Cloning Technology Kits, Chassis Organisms, Xeno-nucleic Acids (XNO)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Food and Agriculture, Environmentals, Industrials, Medicals, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher (US)
- Novozymes (Denmark)
- Merck KGaA (Germany)
- Intrexon (US)
- Agilent Technologies (US)
Highlights of The Gene Synthesis Tool Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oligonucleotides
- Enzymes
- Cloning Technology Kits
- Chassis Organisms
- Xeno-nucleic Acids (XNO)
- By Application:
- Food and Agriculture
- Environmentals
- Industrials
- Medicals
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gene Synthesis Tool Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Gene synthesis tool is a software that helps in the creation of gene sequences.
Some of the key players operating in the gene synthesis tool market are Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), Agilent Technologies (US).
The gene synthesis tool market is expected to grow at a compound annual growth rate of 8.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Gene Synthesis Tool Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Gene Synthesis Tool Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Gene Synthesis Tool Market - Supply Chain
4.5. Global Gene Synthesis Tool Market Forecast
4.5.1. Gene Synthesis Tool Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Gene Synthesis Tool Market Size (000 Units) and Y-o-Y Growth
4.5.3. Gene Synthesis Tool Market Absolute $ Opportunity
5. Global Gene Synthesis Tool Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Gene Synthesis Tool Market Size and Volume Forecast by Type
5.3.1. Oligonucleotides
5.3.2. Enzymes
5.3.3. Cloning Technology Kits
5.3.4. Chassis Organisms
5.3.5. Xeno-nucleic Acids (XNO)
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Gene Synthesis Tool Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Gene Synthesis Tool Market Size and Volume Forecast by Application
6.3.1. Food and Agriculture
6.3.2. Environmentals
6.3.3. Industrials
6.3.4. Medicals
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Gene Synthesis Tool Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Gene Synthesis Tool Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Gene Synthesis Tool Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Gene Synthesis Tool Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Gene Synthesis Tool Demand Share Forecast, 2019-2026
9. North America Gene Synthesis Tool Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Gene Synthesis Tool Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Gene Synthesis Tool Market Size and Volume Forecast by Application
9.4.1. Food and Agriculture
9.4.2. Environmentals
9.4.3. Industrials
9.4.4. Medicals
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Gene Synthesis Tool Market Size and Volume Forecast by Type
9.7.1. Oligonucleotides
9.7.2. Enzymes
9.7.3. Cloning Technology Kits
9.7.4. Chassis Organisms
9.7.5. Xeno-nucleic Acids (XNO)
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Gene Synthesis Tool Demand Share Forecast, 2019-2026
10. Latin America Gene Synthesis Tool Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Gene Synthesis Tool Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Gene Synthesis Tool Market Size and Volume Forecast by Application
10.4.1. Food and Agriculture
10.4.2. Environmentals
10.4.3. Industrials
10.4.4. Medicals
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Gene Synthesis Tool Market Size and Volume Forecast by Type
10.7.1. Oligonucleotides
10.7.2. Enzymes
10.7.3. Cloning Technology Kits
10.7.4. Chassis Organisms
10.7.5. Xeno-nucleic Acids (XNO)
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Gene Synthesis Tool Demand Share Forecast, 2019-2026
11. Europe Gene Synthesis Tool Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Gene Synthesis Tool Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Gene Synthesis Tool Market Size and Volume Forecast by Application
11.4.1. Food and Agriculture
11.4.2. Environmentals
11.4.3. Industrials
11.4.4. Medicals
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Gene Synthesis Tool Market Size and Volume Forecast by Type
11.7.1. Oligonucleotides
11.7.2. Enzymes
11.7.3. Cloning Technology Kits
11.7.4. Chassis Organisms
11.7.5. Xeno-nucleic Acids (XNO)
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Gene Synthesis Tool Demand Share, 2019-2026
12. Asia Pacific Gene Synthesis Tool Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Gene Synthesis Tool Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Gene Synthesis Tool Market Size and Volume Forecast by Application
12.4.1. Food and Agriculture
12.4.2. Environmentals
12.4.3. Industrials
12.4.4. Medicals
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Gene Synthesis Tool Market Size and Volume Forecast by Type
12.7.1. Oligonucleotides
12.7.2. Enzymes
12.7.3. Cloning Technology Kits
12.7.4. Chassis Organisms
12.7.5. Xeno-nucleic Acids (XNO)
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Gene Synthesis Tool Demand Share, 2019-2026
13. Middle East & Africa Gene Synthesis Tool Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Gene Synthesis Tool Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Gene Synthesis Tool Market Size and Volume Forecast by Application
13.4.1. Food and Agriculture
13.4.2. Environmentals
13.4.3. Industrials
13.4.4. Medicals
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Gene Synthesis Tool Market Size and Volume Forecast by Type
13.7.1. Oligonucleotides
13.7.2. Enzymes
13.7.3. Cloning Technology Kits
13.7.4. Chassis Organisms
13.7.5. Xeno-nucleic Acids (XNO)
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Gene Synthesis Tool Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Gene Synthesis Tool Market: Market Share Analysis
14.2. Gene Synthesis Tool Distributors and Customers
14.3. Gene Synthesis Tool Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher (US)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Novozymes (Denmark)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck KGaA (Germany)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Intrexon (US)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Agilent Technologies (US)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook